United States · FDA National Drug Code directory
Solifenacin Succinate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-527_e0e2cc86-60c8-450a-86f8-c551308ff027
- Product NDC
- 67877-527
- Form
- TABLET, FILM COATED
- Composition / generic term
- Solifenacin Succinate
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190521
- Source listing expiry
- 20261231
Source-listed ingredients
- SOLIFENACIN SUCCINATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (67877-527-30) · 67877-527-30
- 10 BLISTER PACK in 1 CARTON (67877-527-38) / 10 TABLET, FILM COATED in 1 BLISTER PACK (67877-527-33) · 67877-527-38
- 90 TABLET, FILM COATED in 1 BOTTLE (67877-527-90) · 67877-527-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →